Literature DB >> 33327994

[Association of fatty acid composition in human milk with breast milk jaundice in neonates].

Li-Fei Yang1, Jing Li, Rui Hu1, Li-Qing Xu1, Ya-Xuan Li1, Wang-Tao Sheng1.   

Abstract

OBJECTIVE: To study the association of fatty acid composition in human milk with breast milk jaundice (BMJ) in neonates.
METHODS: A total of 30 full-term neonates who were admitted to the neonatal intensive care unit from October 2016 to October 2017 and were diagnosed with late-onset BMJ were enrolled as the BMJ group. Thirty healthy neonates without jaundice or pathological jaundice who were admitted to the confinement center during the same period of time were enrolled as the control group. Related clinical data were collected, including sex, mode of birth, feeding pattern, gestational age, birth weight, gravida, parity, and peak level of total serum bilirubin. Breast milk was collected from the mothers, and the MIRIS human milk analyzer was used to measure macronutrients (fat, protein, and carbohydrate) and calorie. Gas chromatography was used to analyze the content of different fatty acids in breast milk.
RESULTS: The control group had higher levels of macronutrients in human milk than the BMJ group, with significant differences in fat, dry matter, and calorie (P < 0.05). In addition, 25 fatty acids were detected in breast milk, including 9 saturated fatty acids, 6 monounsaturated fatty acids, and 10 polyunsaturated fatty acids. The comparison of the percentage composition of different fatty acids showed that compared with the control group, the BMJ group had significantly lower percentage compositions of C15:0, C16:0, C17:0, C18:0, C20:0, C18:1n9t, C20:1n9, C18:3n6, C22:2, and C22:6n3 (DHA) and higher percentage compositions of C10:0, C12:0, C14:0 in breast milk (P < 0.05).
CONCLUSIONS: Some macronutrients and fatty acid composition in human milk may be associated with the pathogenesis of BMJ in neonates.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33327994      PMCID: PMC7735932     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  6 in total

1.  Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.

Authors:  Yoshihiro Maruo; Yoriko Morioka; Hiroshi Fujito; Sayuri Nakahara; Takahide Yanagi; Katsuyuki Matsui; Asami Mori; Hiroshi Sato; Robert H Tukey; Yoshihiro Takeuchi
Journal:  J Pediatr       Date:  2014-03-17       Impact factor: 4.406

Review 2.  [Research progress on the relationship between SLCO1B1 gene and neonatal jaundice].

Authors:  An-Feng Lu; Dan-Ni Zhong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2014-11

3.  Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis.

Authors:  Shaoming Zhou; Zhangxing Wang; Fusheng He; Huixian Qiu; Yan Wang; Huihui Wang; Jianli Zhou; Jiaxiu Zhou; Guoqiang Cheng; Wenhao Zhou; Ruihuan Xu; Mingbang Wang
Journal:  J Nutr Biochem       Date:  2018-09-26       Impact factor: 6.048

Review 4.  Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Yoshihiro Maruo; Shujuan Chen; Robert H Tukey
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-02       Impact factor: 4.219

5.  Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats.

Authors:  Jianrong Han; James A Hamilton; James L Kirkland; Barbara E Corkey; Wen Guo
Journal:  Obes Res       Date:  2003-06

6.  Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia.

Authors:  Ayako Shibuya; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Sci Rep       Date:  2013-10-09       Impact factor: 4.379

  6 in total
  1 in total

1.  Risk factors for neonatal hyperbilirubinemia: a systematic review and meta-analysis.

Authors:  Qun Lin; Daomou Zhu; Caihua Chen; Yonghong Feng; Fenfen Shen; Zhenkui Wu
Journal:  Transl Pediatr       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.